The field of urologic oncology is experiencing rapid advancements in recent years, fueled by innovations in diagnosis, treatment, and patient care. Innovative therapeutic strategies such as targeted therapy and immunotherapy are altering the landscape of urologic cancer treatment. Additionally, advancements in imaging techniques enable earlier and